<?xml version="1.0" encoding="ISO-8859-1"?>  
  
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
  
 <channel>  
 <title>CsBioactive - Consumer</title>  
 <link>http://www.csbioactive.com</link>  
 <description>CsBioactive - The most researched brand of chondroitin sulfate</description>  
 <language>es</language>  

 <item>
 <title><![CDATA[Bioiberica's perspective on Chondroitin Meta-Analysis]]></title>
<description><![CDATA[Bioiberica, as a Spanish chondroitin manufacturer has weighed in on the debate over the negative results of the meta-analysis recently published in the Annals of Internal Medicine and would like to make a series of considerations of interest for the use of CS in daily clinical practice by the hand of Josep Vergés, Bioiberica´s scientific director:]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=10]]></link></item>

 <item>
 <title><![CDATA[Editorial, Trade Groups Offer Perspective On Null Chondroitin Meta-Analysis]]></title>
<description><![CDATA[Patients should continue taking chondroitin sulfate for osteoarthritis if they perceive a benefit, despite a recent study that found a null effect, according to an accompanying editorial in the April 17 Annals of Internal Medicine.]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=9]]></link></item>

 <item>
 <title><![CDATA[Experts Address Chondroitin Testing In Wake Of ConsumerLab Report]]></title>
<description><![CDATA[Experts see educational opportunity in ConsumerLab joint supplement report finding chondroitin levels in 7 of 11 products failed to meet label claims. Analytical scientists, industry execs not surprised by report, citing firms inappropriate testing. Experts stress use of AOAC enzymatic HPLC method, update its status on becoming official method.]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=8]]></link></item>

 <item>
 <title><![CDATA[Chondroitin Meta-Analysis Misses Mark]]></title>
<description><![CDATA[BERN, Switzerland - A meta-analysis published in the April issue of the Annals of Internal Medicine (146, 8:580-90, 2007) concluded chondroitin supplementation has minimal to no effect on osteoarthritis (OA); but, nutrition industry insiders point to many flaws in the review design, including undefined OA endpoints and a severely limited number of trials used to reach its conclusion.]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=7]]></link></item>

 <item>
 <title><![CDATA[Debate on chondroitin's effectiveness goes on]]></title>
<description><![CDATA[A Spanish chondroitin sulfate manufacturer has weighed in on the debate over the negative results of a meta-analysis recently published in the Annals of Internal Medicine.]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=6]]></link></item>

 <item>
 <title><![CDATA[Limited Meta-Analysis doesn't represent reality of population with OsteoArthritis.]]></title>
<description><![CDATA[]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=5]]></link></item>

 <item>
 <title><![CDATA[Chondroitin & Glucosamine: The best of both worlds.]]></title>
<description><![CDATA[The clinical efficacy of prescription drugs and the safety of products of natural origin]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=4]]></link></item>

 <item>
 <title><![CDATA[Video - Positive Results on CSbBio-ActiveTM on OA Treatment]]></title>
<description><![CDATA[]]></description>
<link><![CDATA[ http://www.csbioactive.com/doc.php?op=c_news2&id=1]]></link></item>
    
 </channel>  
</rss> 